INMB Inmune Bio, Inc.
8-K Current Report
Filed: February 27, 2026
Health Care
Biological Products, (No Diagnostic Substances)Inmune Bio, Inc. (INMB) 8-K current report filed with SEC EDGAR on February 27, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 7.01: Regulation FD Disclosure
AI Filing Analysis8-K
Item 7.01 · Regulation FD Disclosure
- • Inmune Bio filed a Reg FD disclosure (Item 7.01), signaling material non-public information is being broadly released to maintain fair market access
- • Filing text contains no substantive disclosed information — full content likely resides in an accompanying exhibit (e.g., Exhibit 99.1)
Other Inmune Bio, Inc. 8-K Filings
Get deeper insights on Inmune Bio, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.